AKT1 and colorectal carcinoma: [9] The current results indicate that CHRNA7-Ca2+-PI3K-PIP3-AKT-(MTOR, NFkβ, BIRC5) is a key target signaling pathway of the activity of active components in coix seed for treatment of CRC.